MedCity News

APRIL 9, 2024

The post Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect? The finalists for the Payer/Provider track are applying their health tech solutions to addressing burnout and operational efficiency. appeared first on MedCity News.

105

105

Medical Device Success

OCTOBER 11, 2020

Reading time: 2 – 3 minutes In past episodes of the podcast and video cast, we have covered various components of virtual presentations and virtual selling. BrightCarbon is a presentation design company that has worked with life science companies of all sizes to help them communicate their stories and value propositions. .

Doctors 100

Doctors Medical Sales Marketing 100

Contrarian Sales Techniques

FEBRUARY 23, 2023

Based on this blog post , it looks like the presentation structure and style involves the following key elements: 1. Strong opening : Begin the presentation with a strong opening that grabs the audience's attention and sets the tone for the rest of the presentation.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

PharmaTimes

JANUARY 19, 2024

Company will present vital findings at SRI annual meeting

93

93

Pharmacy Times

APRIL 16, 2024

Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.

Ethics 49

Ethics Medicine 49

European Pharmaceutical Review

SEPTEMBER 7, 2023

The post Alzheimer’s senescent cell combination therapy presents promise appeared first on European Pharmaceutical Review. A larger $3 million, Phase II clinical trial is in process, with the aim to test the effects of clearing senescent cells with the combination therapy, the paper noted.

Food and Drug Administration 98

Food and Drug Administration Medicine Food FDA 98

Fierce Pharma

OCTOBER 30, 2024

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the British drugmaker.

Sales 231

Sales 231

European Pharmaceutical Review

JUNE 20, 2023

Key highlights from the presentation include: CHK-336 was generally well tolerated in HVs who received single doses up to 500mg and multiple doses (14 days) up to 60mg. Participants in the MAD portion of the study received placebo or multiple doses of the oral small molecule CHK-336, ranging from 30mg to 500mg given daily for 14 days.

Distribution 98

Distribution Pharmaceutical Patients 98

Medical Device Success

SEPTEMBER 13, 2020

Virtual presentations are key and you must know how to best use the tools at hand. The post Episode 23 – Making Your Virtual Presentations More Powerful! Virtual presentations are key and you must know how to best use the tools at hand. One of the biggest is the changes in how we communicate.

Medical 100

Medical Marketing Management Sales 100

eatNgage

FEBRUARY 18, 2022

Tips to Ace Your Virtual Sales Presentation. Giving a virtual sales presentation can be nerve-wracking. In this blog post, we will give you tips on how to ace your virtual sales presentation every time! 1) Schedule with your prospect Before you can deliver your presentation, you need an audience to deliver it to!

Sales presentations 52

Sales presentations Sales Prospecting 52

Pharmacy Times

JULY 18, 2024

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

Safety 55

Safety 55

MedCity News

DECEMBER 18, 2022

Many (not all) physician-/scientist-CEOs have a tendency to revert to their area of comfort by using highly scientific terminology and concepts in ways that derail from the purpose of the presentation: articulating the business case in a finite amount of meeting time.

Marketing 97

Marketing Physicians Biopharma 97

MedCity News

MAY 19, 2023

Companies presenting their technology at the conference seek to support a diverse patient population spanning conditions such as inflammatory bowel disease, food allergies, and cancer. Cell, gene therapy and immunotherapies also form some of their treatment approaches in development.

Biopharma 60

Biopharma Food Patients 60

Fierce Pharma

OCTOBER 22, 2024

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job in a new presentation. Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

Management 314

Management 314

PharmExec

JUNE 13, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses data presented at ASCO from ABBV-400 and ABBV-706 in multiple studies.

52

52

PharmExec

JUNE 13, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses data presented at ASCO from ABBV-400 and ABBV-706 in multiple studies.

52

52

PharmaTech

MAY 9, 2024

The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy.

52

52

European Pharmaceutical Review

AUGUST 25, 2022

The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl med. 2019;17:271.

Side effects 111

Side effects Safety Patients Engineering 111

MedCity News

JUNE 1, 2023

A new decentralized network of the future exists and is in operation today. Large payers and providers are already beginning to use it for administrative transactions, although clinical transactions are also envisioned.

Networking 106

Networking 106

PharmaTimes

NOVEMBER 6, 2024

Phase 1 and 2 studies show promising results for anito-cel therapy

89

89

Fierce Pharma

JULY 31, 2024

On the heels of game-changing trial results presented at la | On the heels of game-changing trial results presented at last year's ASH meeting, J&J is introducing what it calls a "foundational frontline therapy" in multiple myeloma and at the same time expanding its already impressive presence in the field.

FDA 247

FDA 247

Contrarian Sales Techniques

DECEMBER 4, 2023

It’s a mobile showcase, a silent yet persuasive partner in every pitch and presentation. A chaotic bag can lead to a chaotic presentation. In the realm of pharma, where the presentation of drug samples is as critical as the information relayed, these bags serve a pivotal role. The sample bag they carry isn’t just a container.

Sales 52

Sales Pharmaceutical Sales Pharma Transportation 52

Pharmaceutical Technology

NOVEMBER 7, 2023

At AAO 2023, results were presented from the Phase IIa trial of Allgenesis’ AG-73305, evaluating its application for the treatment of DME.

59

59

Pharmaceutical Commerce

DECEMBER 18, 2023

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

104

104

Fierce Pharma

OCTOBER 16, 2024

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from Gilead Sciences, the company has presented strong results from three real-world studies of its bi-monthly injection for HIV prevention.

Competition 256

Competition 256

Medical Device Success

APRIL 19, 2020

Is a Virtual PowerPoint presentation the same as a face to face PowerPoint? The post Episode 5 – Make Your Virtual PowerPoint Presentation Powerful in this Covid-19 World appeared first on Medical Device Success - Ideas You Can Put To Work Today! Is a Virtual PowerPoint presentation the same as a face to face PowerPoint?

Medical 100

Medical Sales Management Management Marketing 100

Fierce Pharma

OCTOBER 31, 2024

25 mg presentation of the popular metabolic medicine was the last dose of either Wegovy or its type 2 diabetes sibling Ozempic to be listed as in shortage by the FDA. 25 mg starter dose of Novo’s semaglutide-based obesity med Wegovy is now available in the U.S.

FDA 286

FDA Medicine 286

Fierce Pharma

AUGUST 2, 2024

This week on “The Top Line,” we discuss two studies in HIV research that were presented at the 25th International AIDS | This week on “The Top Line,” we dive into two studies in HIV research that were presented at the 25th International AIDS Conference in Germany.

Patients 201

Patients 201

Fierce Pharma

OCTOBER 31, 2024

AstraZeneca executives past and present are under investigation in China. AstraZeneca executives past and present are under investigation in China. GSK is paying $300 million upfront to obtain a T-cell engager to develop for autoimmune diseases. Takeda has hit a setback with its orexin receptor 2 agonist danavorexton.

Pharma 130

Pharma 130

Pharmacy Times

DECEMBER 11, 2023

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

Patients 52

Patients 52

pharmaphorum

DECEMBER 5, 2022

A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.

Medicine 59

Medicine Safety FDA Patients 59

PharmaTimes

OCTOBER 2, 2024

Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid

93

93

PharmaTech

APRIL 2, 2024

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

52

52

Fierce Pharma

OCTOBER 16, 2024

While radiopharmaceuticals have attracted significant interest in recent years thanks to their cancer-fighting prowess, the unique makeup of the meds has presented a host of production challenges f | SpectronRx has inked an agreement to complete its first European radiolabeling plant at the Belgian Nuclear Research Center in Mol, Belgium.

222

222

Fierce Pharma

OCTOBER 30, 2024

As part of the new budget presented Wednesday by the U.K.’s Biopharma production efforts are set to receive a big boost in the U.K. thanks to a new budget rolled out by the Labour Party following this summer’s general election. |

Manufacturing 233

Manufacturing Biopharma Medical 233

Fierce Pharma

APRIL 29, 2024

After last quarter presenting three factors necessary for a more successful launch of hemophilia A gene therapy Roctavian, BioMarin has now added a divestiture to the list of potenti | After last quarter presenting three factors necessary for a more successful launch of hemophilia A gene therapy Roctavian, BioMarin has now added a divestiture to the (..)

Sales 214

Sales Medicine 214

Fierce Pharma

JANUARY 10, 2024

In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist. | In his first presentation as the new CEO of BioMarin, Alexander Hardy left no doubt about his mission for the rare and genetic disease specialist.

241

241